日本脳炎ワクチンの世界市場2019-2023

◆英語タイトル:Global Japanese Encephalitis Vaccines Market 2019-2023
◆商品コード:IRTNTR31555
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年6月26日
◆ページ数:131
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア、ヨーロッパ、北米、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Technavio社の本調査レポートでは、日本脳炎ワクチンの世界市場について調べ、日本脳炎ワクチンの市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、日本脳炎ワクチンの市場規模をセグメンテーション別(種類別(不活化ワクチン、組み換えワクチン、弱毒化生ワクチン)、)と地域別(アジア、ヨーロッパ、北米、その他)に分けて算出しました。Technavio社は日本脳炎ワクチンの世界市場規模が2019-2023期間中に年平均9%成長すると予測しています。
・サマリー
・レポートの範囲
・日本脳炎ワクチンの市場状況
・日本脳炎ワクチンの市場規模
・日本脳炎ワクチンの市場予測
・日本脳炎ワクチンの世界環境:ファイブフォース分析
・市場セグメンテーション:種類別(不活化ワクチン、組み換えワクチン、弱毒化生ワクチン)
・日本脳炎ワクチンの顧客状況
・主要地域別市場規模:アジア、ヨーロッパ、北米、その他
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global Japanese Encephalitis Vaccines Market: About this market

Japanese encephalitis is an inflammation in the brain, which is usually asymptomatic and is caused by a mosquito-borne flavivirus. Technavio’s Japanese encephalitis vaccines market analysis considers sales from different type, including inactivated vaccines, recombinant vaccines, and live attenuated vaccines. Our analysis also considers the sales of Japanese encephalitis vaccines in Asia, Europe, North America, and ROW. In 2018, the inactivated vaccines segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing number of choices and wide treatment options of the segment will play a significant role in the inactivated vaccines segment to maintain its market position. Also, our global Japanese encephalitis vaccines market report looks at factors such as the inclusion in national immunization plan, strategic alliances, and a growing number of awareness campaigns. However, demand-supply imbalance, geographic concentration, and weak pipeline may hamper the growth of the Japanese encephalitis vaccines industry over the forecast period.

Global Japanese Encephalitis Vaccines Market: Overview

Inclusion in national immunization plan

National immunization plans to prevent the high risk of Japanese encephalitis involves mass vaccinations. This plan results in an increased procurement of vaccination doses. The inclusion of vaccination against Japanese encephalitis in national immunization plans will lead to the expansion of the global Japanese encephalitis vaccines market at a CAGR of almost 9% during the forecast period.

Strong investments from BRICS in research

With the growing incidence of Japanese encephalitis, BRICS is developing vaccines against the indication. Pharmaceutical companies are supporting the development of these vaccines by investing in research and developmental activities. The presence of strong manufacturing facilities in BRICS countries is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global Japanese encephalitis vaccines market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global Japanese encephalitis vaccines market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Japanese encephalitis vaccines manufacturers, that include Bharat Biotech Ltd., Biological E. Ltd., Green Cross Corp., Sanofi, and Valneva SE.

Also, the Japanese encephalitis vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06:  MARKET SEGMENTATION BY TYPE

Market segmentation by type

Comparison by type

Inactivated vaccines – Market size and forecast 2018-2023

Recombinant vaccines – Market size and forecast 2018-2023

Live attenuated vaccines – Market size and forecast 2018-2023

Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

North America – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

Novel vaccine technology

Strong investments from BRICS in research

Growing inbound travel to Asia

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Bharat Biotech Ltd.

Biological E. Ltd.

Green Cross Corp.

Sanofi

Valneva SE

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Product overview

Exhibit 02: Global pharmaceuticals market

Exhibit 03: Segments of global pharmaceuticals market

Exhibit 04: Market characteristics

Exhibit 05: Market segments

Exhibit 06: Market definition – Inclusions and exclusions checklist

Exhibit 07: Market size 2018

Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 10: Five forces analysis 2018

Exhibit 11: Five forces analysis 2023

Exhibit 12: Bargaining power of buyers

Exhibit 13: Bargaining power of suppliers

Exhibit 14: Threat of new entrants

Exhibit 15: Threat of substitutes

Exhibit 16: Threat of rivalry

Exhibit 17: Market condition – Five forces 2018

Exhibit 18: Type – Market share 2018-2023 (%)

Exhibit 19: Comparison by type

Exhibit 20: Inactivated vaccines – Market size and forecast 2018-2023 ($ millions)

Exhibit 21: Inactivated vaccines – Year-over-year growth 2019-2023 (%)

Exhibit 22: Recombinant vaccines – Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Recombinant vaccines – Year-over-year growth 2019-2023 (%)

Exhibit 24: Live attenuated vaccines – Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Live attenuated vaccines – Year-over-year growth 2019-2023 (%)

Exhibit 26: Market opportunity by type

Exhibit 27: Customer landscape

Exhibit 28: Market share by geography 2018-2023 (%)

Exhibit 29: Geographic comparison

Exhibit 30: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 32: Top 3 countries in Asia

Exhibit 33: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 35: Top 3 countries in ROW

Exhibit 36: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 37: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 38: Top 3 countries in Europe

Exhibit 39: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 40: North America – Year-over-year growth 2019-2023 (%)

Exhibit 41: Top 3 countries in North America

Exhibit 42: Key leading countries

Exhibit 43: Market opportunity

Exhibit 44: Impact of drivers and challenges

Exhibit 45: Vendor landscape

Exhibit 46: Landscape disruption

Exhibit 47: Vendors covered

Exhibit 48: Vendor classification

Exhibit 49: Market positioning of vendors

Exhibit 50: Bharat Biotech Ltd. – Vendor overview

Exhibit 51: Bharat Biotech Ltd. – Business segments

Exhibit 52: Bharat Biotech Ltd. – Organizational developments

Exhibit 53: Bharat Biotech Ltd. – Key offerings

Exhibit 54: Bharat Biotech Ltd. – Key customers

Exhibit 55: Biological E. Ltd. – Vendor overview

Exhibit 56: Biological E. Ltd. – Business segments

Exhibit 57: Biological E. Ltd. – Organizational developments

Exhibit 58: Biological E. Ltd. – Key offerings

Exhibit 59: Biological E. Ltd. – Key customers

Exhibit 60: Green Cross Corp. – Vendor overview

Exhibit 61: Green Cross Corp. – Business segments

Exhibit 62: Green Cross Corp. – Organizational developments

Exhibit 63: Green Cross Corp. – Geographic focus

Exhibit 64: Green Cross Corp. – Segment focus

Exhibit 65: Green Cross Corp. – Key offerings

Exhibit 66: Green Cross Corp. – Key customers

Exhibit 67: Sanofi – Vendor overview

Exhibit 68: Sanofi – Business segments

Exhibit 69: Sanofi – Organizational developments

Exhibit 70: Sanofi – Geographic focus

Exhibit 71: Sanofi – Segment focus

Exhibit 72: Sanofi – Key offerings

Exhibit 73: Sanofi – Key customers

Exhibit 74: Valneva SE – Vendor overview

Exhibit 75: Valneva SE – Business segments

Exhibit 76: Valneva SE – Organizational developments

Exhibit 77: Valneva SE – Geographic focus

Exhibit 78: Valneva SE – Segment focus

Exhibit 79: Valneva SE – Key offerings

Exhibit 80: Valneva SE – Key customers

Exhibit 81: Validation techniques employed for market sizing

Exhibit 82: Definition of market positioning of vendors



【掲載企業】

Bharat Biotech Ltd.
Biological E. Ltd.
Green Cross Corp.
Sanofi
Valneva SE.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[日本脳炎ワクチンの世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆